Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$701K Hold
1,935
0.2% 51
2026
Q1
$681K Hold
1,935
0.23% 50
2025
Q4
$633K Sell
1,935
-445
-19% -$141K 0.22% 53
2025
Q3
$672K Hold
2,380
0.26% 52
2025
Q2
$665K Hold
2,380
0.28% 48
2025
Q1
$741K Hold
2,380
0.33% 46
2024
Q4
$620K Hold
2,380
0.29% 49
2024
Q3
$767K Hold
2,380
0.37% 46
2024
Q2
$744K Hold
2,380
0.4% 44
2024
Q1
$677K Hold
2,380
0.38% 44
2023
Q4
$686K Sell
2,380
-146
-6% -$39.8K 0.42% 41
2023
Q3
$679K Hold
2,526
0.48% 39
2023
Q2
$561K Hold
2,526
0.4% 40
2023
Q1
$611K Hold
2,526
0.46% 36
2022
Q4
$663K Buy
+2,526
New +$677K 0.51% 37

Other funds holding AMGN

CPA Asset Management's AMGN Position: Q2 2026 in Review

CPA Asset Management held its Amgen (AMGN) position steady in Q2 2026 at 1,935 shares worth $701K. The position accounts for 0.2% of the portfolio, ranked #51.

CPA Asset Management first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $767K in Q3 2024. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • CPA Asset Management held 1,935 shares of Amgen worth $701K as of Q2 2026.
  • CPA Asset Management left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.2% of CPA Asset Management's portfolio in Q2 2026, its #51 holding.
  • CPA Asset Management first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • CPA Asset Management's Amgen position peaked at $767K in Q3 2024.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on CPA Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.